Akili (NASDAQ:AKLI – Get Rating) and GlucoTrack (NASDAQ:GCTK – Get Rating) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, earnings, valuation, profitability, risk and dividends. Volatility & Risk Akili has a beta of 1.18, indicating that […]